Completed PHASE1 INTERVENTIONAL 1-arm NCT00268307

Bone Marrow Stem Cell Infusion Following a Heart Attack

Cellular Transplantation of Autologous Bone Marrow-Derived Stem Cells Following Myocardial Infarction

Sponsor: Allina Health System

Interventions Autologous, Unfractionated Bone Marrow Mononuclear Cells

Updated 7 times since 2017 Last updated: Dec 3, 2013 Started: Dec 31, 2005 Primary completion: Jan 31, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00268307, this PHASE1 trial focuses on Acute Myocardial Infarction and remains completed. Sponsored by Allina Health System, it has been updated 7 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Apr 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Apr 2019 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allina Health System
Minneapolis Heart Institute Foundation

Data source: Minneapolis Heart Institute Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States